› › Acorda Therapeutics

ACOR

Acorda Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Acorda Therapeutics Inc ACOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 7.60 19:01:21
Open Price Low Price High Price Close Price Prev Close
7.815 7.10 7.815 7.44 7.60
more quote information »

Recent News

Date Time Source Heading
1/15/202120:19TRMNAcorda Stock at $35 a Share? This Analyst Thinks It’s..
1/13/202107:31EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
1/13/202107:13EDGARCurrent Report Filing (8-k)
1/12/202116:07BWAcorda Therapeutics to Present at 39th Annual J.P. Morgan..
1/11/202116:20BWAcorda Therapeutics to Present at H.C. Wainwright BIOCONNECT..
12/31/202016:19BWAcorda Therapeutics Announces Completion of One-for-Six..
12/10/202009:10EDGARAmended Statement of Ownership (sc 13g/a)
12/01/202017:07EDGARCurrent Report Filing (8-k)
11/12/202007:44EDGARStatement of Changes in Beneficial Ownership (4)
11/03/202016:10EDGARCurrent Report Filing (8-k)
11/03/202016:00BWAcorda Reports Third Quarter 2020 Financial Results
10/27/202007:00BWAcorda Third Quarter 2020 Update: Webcast/Conference Call..
10/19/202016:47EDGARCurrent Report Filing (8-k)
10/05/202017:03EDGARCurrent Report Filing (8-k)
9/21/202008:36EDGARStatement of Changes in Beneficial Ownership (4)
9/21/202008:32EDGARStatement of Changes in Beneficial Ownership (4)
9/21/202008:30EDGARStatement of Changes in Beneficial Ownership (4)
9/18/202006:07EDGARNotice of Effectiveness (effect)
9/17/202016:43EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
9/17/202007:00GLOBEAravive Appoints Michael W. Rogers to Board of Directors
9/11/202014:27EDGARSecurities Registration Statement (simplified Form) (s-3)
9/11/202007:06EDGARSecurities Registration Statement (simplified Form) (s-3)
8/31/202016:40EDGARCurrent Report Filing (8-k)
8/28/202010:01EDGARCurrent Report Filing (8-k)
8/20/202016:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/17/202016:22EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/17/202016:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/10/202016:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/10/202009:26EDGARAmended Statement of Ownership (sc 13g/a)
8/10/202006:08EDGARQuarterly Report (10-q)
8/04/202017:48EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/04/202016:03EDGARCurrent Report Filing (8-k)
8/04/202016:00BWAcorda Reports Second Quarter 2020 Financial Results
8/03/202016:27EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/31/202012:59EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/31/202012:48EDGARCurrent Report Filing (8-k)
7/31/202012:45BWAcorda Therapeutics Announces Adjournment of Special Meeting..
7/28/202007:00BWAcorda Second Quarter 2020 Update: Webcast/Conference Call..
7/27/202017:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/27/202017:07EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/24/202016:46EDGARCurrent Report Filing (8-k)
7/21/202016:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/14/202016:06EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/14/202016:03EDGARCurrent Report Filing (8-k)
7/10/202010:45EDGARAmended Statement of Ownership (sc 13g/a)
7/07/202006:03EDGARNotice of Effectiveness (effect)
7/06/202017:13EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
7/06/202009:26EDGARProxy Statement (definitive) (def 14a)
6/29/202009:01EDGARProxy Statement - Notice of Shareholders Meeting..
6/29/202008:40EDGARSecurities Registration Statement (simplified Form) (s-3)
See more news about this stock »
Your Recent History
NASDAQ
ACOR
Acorda The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210126 00:30:51